Berland v. The Conclave, LLC

CourtDistrict Court, S.D. California
DecidedMarch 20, 2023
Docket3:20-cv-00922
StatusUnknown

This text of Berland v. The Conclave, LLC (Berland v. The Conclave, LLC) is published on Counsel Stack Legal Research, covering District Court, S.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Berland v. The Conclave, LLC, (S.D. Cal. 2023).

Opinion

1 2 3 4 5 UNITED STATES DISTRICT COURT 6 SOUTHERN DISTRICT OF CALIFORNIA 7 8 BRIAN G. BERLAND, et. al., Case No.: 20-cv-00922-H-WVG

9 Petitioners, ORDER: 10 v. (1) DENYING PAGE 11 THE CONCLAVE, LLC, et al., RESPONDENTS’ MOTION TO 12 Respondents. CONFIRM, IN PART, AND VACATE, IN PART, FINAL 13 ARBITRAL AWARD; AND 14 [Doc. No. 105] 15

16 (2) GRANTING PROGENEX’S CROSS-MOTION TO CONFIRM 17 FINAL ARBITRAL AWARD 18 [Doc. No. 112.] 19

21 On December 29, 2022, Respondents Dagobah LLC, Page10 Ventures, LLC, and 22 Ryan Page (the “Page Respondents”) filed a motion requesting that the Court confirm, in 23 part, and vacate, in part, a final award issued in arbitration on September 30, 2022 (the 24 “Final Award”) against Petitioners Brian G. Berland, Laurita Berland, Vincent Berland, 25 Roxane M. Blake, Aaron Bollig, Steve Burns, Troy E. Burns, Michael Carey, Patrick 26 Carey, Michael Carpenter, Sonya Carpenter, Merrill Conant, Ross Edwards, Kevin Fralick, 27 Tom Gawlick, Justin Jones, William Kalahurka, Jeffrey Menzie, Pamela Menzie, Progenex 28 1 Investment Group, LLC, D. Paul Rittman, David Schmidt, Scott Schneider, Mark Shields, 2 The Shields Group, LLC, Michael Speer, Dennis Stanley, Gail Stanley, Ronnie Stanley, 3 Randy Staten, Gina Staten, Curtis L. Thomas, Nancy L. Thomas, Carol Thomeczek, 4 William D. Turley, Sheri Turley, Gavin Unruh, Kimberly Unruh, Annetta Vahsholtz, 5 Dennis Vahsholtz, Richard Weiser, Roger Winter, Timothy C. Winter, Jimmy Woodward, 6 Larry Woodward, Mark Zortman, and Anita Zortman (“Petitioners”). (Doc. No. 105 7 (“Page Respondents’ Motion”).) On January 30, 2023, Respondent Progenex Holdings, 8 LLC (“Progenex”) filed an opposition to the Page Respondents’ Motion and cross-moved 9 the Court to confirm the Final Award. (Doc. No. 112 (“Progenex’s Cross-Motion”).) On 10 January 30, 2023, Third-Party Respondent Cameron N. Verdi (“Verdi”) filed an opposition 11 to the Page Respondents’ Motion and a response in support of Progenex’s Cross-Motion. 12 (Doc. No. 113.) On January 31, 2023, Petitioners filed a joinder in support of Progenex’s 13 Cross-Motion. (Doc. No. 114.) On February 17, 2023, the Page Respondents filed a 14 consolidated opposition to Progenex’s Cross-Motion and a reply in support of their motion 15 to confirm, in part, and vacate, in part, the Final Award. (Doc. No. 118.) On March 2, 16 2023, Progenex filed a reply in support of its cross-motion to confirm the Final Award. 17 (Doc. No. 123.) 18 The Court, pursuant to its discretion under Local Rule 7.1(d)(1), determines that the 19 motions are fit for resolution without oral argument and submits the motions on the parties’ 20 papers. (Doc. No. 121.) For the reasons that follow, the Court denies the Page 21 Respondents’ Motion and grants Progenex’s Cross-Motion. 22 I. BACKGROUND 23 These motions stem from an arbitration between the parties related to the Progenex 24 enterprise. (Doc. No. 10-2 Ex. 1 at 3.) The Page Respondents are a group of management 25 and holding companies and their principals who managed the Progenex enterprise. (Doc. 26 No. 34 at 2.) Until his July 15, 2020 resignation, Respondent Ryan Page was the manager 27 of Progenex. (Doc. No. 34-1 Ex. 1 at 6.) Petitioners are a group of passive investors in the 28 Progenex enterprise that filed a demand for arbitration regarding various federal and state 1 law securities claims, breach of fiduciary duty/corporate waste, and wrongful dilution. 2 (Doc. No. 10-2 Ex. 1 at 2–3.) 3 A. The Arbitration Agreement 4 Petitioners initiated the arbitration pursuant to the First Amended and Restated 5 Operating Agreement of Mercury Ventures LLC, a Wyoming limited liability company 6 (the “Agreement”). (Doc. No. 106-3 Ex. C at 32.) The Agreement provides for “binding 7 arbitration by a Judicial Arbitration and Mediation Service (“JAMS”) arbitrator.” (Id.) 8 The Agreement thereby incorporates the JAMS Comprehensive Arbitration Rules and 9 Procedures (the “JAMS Rules”). The JAMS Rules allow the Arbitrator to grant “any 10 remedy or relief that is just and equitable and within the scope of the Parties Agreement, 11 including, but not limited to, specific performance of a contract or any other equitable or 12 legal remedy.” JAMS Rule 24(c). The Agreement also requires that “[t]he award shall be 13 made within ninety (90) days from the date the arbitration proceedings are initiated.” (Id. 14 at 32.) 15 The parties submitted a Joint First Amended Statement of Claims that became the 16 operative pleading in the arbitration. (Doc. No. 106-7 Ex. G.) In it, the claimants–the 17 Petitioners in the present case–brought several causes of actions and requested, among 18 other things: 19 “a temporary restraining order, preliminary injunction, and permanent injunction immediately removing Page (and Shamion and Luke Adams and 20 Paul Gomez) from any and all positions as Managers in the Progenex 21 organization, appointing independent replacement Co-Managers, and restraining Respondents from using, selling, transferring, hypothecating or 22 otherwise dissipating or disposing of the funds and assets transferred to them.” 23 (Id. at 91-92.) 24 B. The Initial Proceedings and Interim Award 25 Petitioners initiated the underlying arbitration before JAMS on January 27, 2016. 26 (Doc. No. 106-23 Ex. W at 2.) The Arbitrator held the arbitration hearing in March 2018. 27 (Id.) On February 4, 2019, the Arbitrator issued an Interim Award. (Id. at 28.) In the 28 1 Interim Award, the Arbitrator found that the Petitioners “have failed to prove their [i] 2 federal and state securities law claims . . ., [ii] dilution, and [iii] breach of fiduciary 3 duty/corporate waste claims against Respondents” (the “Original Claims”). (Id. at 3.) 4 The Arbitrator also concluded that “while the dilution transactions were legally 5 permissible and valid, the degree to which the passive investors were diluted . . . was 6 inequitable.” (Id. at 22.) “[T]o ameliorate the extent of the dilution of the Passive Investor 7 [Petitioners]’ shareholder interests in Progenex,” the Arbitrator “exercise[d] her equitable 8 authority,” and ordered the adjustment of ownership interests in Progenex. (Id. at 3.) The 9 Arbitrator ordered the Petitioners’ percentage interest in Progenex to be increased “51% 10 on a pro rata basis,” which would be derived from a reduction in the interests of Aaron 11 Thomas (“Thomas”), Verdi, River Pine LLC, and Conclave members. (Id. at 26–27.) 12 The Arbitrator also provided that Petitioners “failed to establish that Respondents 13 have engaged in legally actionable conduct justifying the removal of Ryan Page from his 14 position as manager of Progenex.” (Id.) To conclude, the Interim Award stated that 15 “[e]xcept as otherwise provided herein, all claims, counter-claims, and affirmative defenses 16 asserted by or between any parties hereto are hereby dismissed with prejudice.” (Id. at 28.) 17 C. Order Reopening Arbitration Hearing 18 On July 31, 2019, the Arbitrator entered an Order Reopening the Arbitration Hearing 19 to review allegedly new material evidence. (Doc. No. 23-2 Ex. A at 1.) The Arbitrator 20 specified that the hearing was being reopened “for limited purposes and for a narrowly 21 limited period of time,” and noted that the “Arbitration has been a very protracted and 22 difficult one . . . and it must be brought to conclusion without further unnecessary delay.” 23 (Id. at 1–2.) The Petitioners and Verdi submitted voluminous exhibits containing new 24 evidence and the parties filed briefing regarding it. (Doc. No. 34-1 Ex. 1 at 4.) 25 In December 2019, the Arbitrator reviewed the new evidence. (Id.) On December 26 20, 2019, Petitioners alerted the Arbitrator of certain “urgent developments related to the 27 Progenex business which likely would affect the status quo of the parties and/or 28 conservation of property and assets” related to the underlying arbitration.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

First Options of Chicago, Inc. v. Kaplan
514 U.S. 938 (Supreme Court, 1995)
Buckeye Check Cashing, Inc. v. Cardegna
546 U.S. 440 (Supreme Court, 2006)
Hall Street Associates, L. L. C. v. Mattel, Inc.
552 U.S. 576 (Supreme Court, 2008)
Lagstein v. CERTAIN UNDERWRITERS, LLOYD'S, LONDON
607 F.3d 634 (Ninth Circuit, 2010)
Florasynth, Inc. v. Alfred Pickholz
750 F.2d 171 (Second Circuit, 1984)
Biller v. Toyota Motor Corp.
668 F.3d 655 (Ninth Circuit, 2012)
Oxford Health Plans LLC v. Sutter
133 S. Ct. 2064 (Supreme Court, 2013)
Qorvis Communications, LLC v. Wilson
549 F.3d 303 (Fourth Circuit, 2008)
Kevin Ferguson v. Corinthian Colleges, Inc.
733 F.3d 928 (Ninth Circuit, 2013)
Comedy Club, Inc. v. Improv West Associates
553 F.3d 1277 (Ninth Circuit, 2009)
In Re Bosack v. Soward
586 F.3d 1096 (Ninth Circuit, 2009)
Collins v. D.R. Horton, Inc.
505 F.3d 874 (Ninth Circuit, 2007)
Romero v. Citibank USA, National Ass'n
551 F. Supp. 2d 1010 (E.D. California, 2008)
Major League Baseball Players Assn. v. Garvey
532 U.S. 504 (Supreme Court, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
Berland v. The Conclave, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/berland-v-the-conclave-llc-casd-2023.